FACULTAD DE CIENCIAS BIOMÉDICAS Y DE LA SALUD
Facultad
University of Vienna
Viena, AustriaPublicaciones en colaboración con investigadores/as de University of Vienna (7)
2020
-
Combined MEK and PI3K/p110β inhibition as a novel targeted therapy for malignant mesothelioma displaying sarcomatoid features
Cancer Research, Vol. 80, Núm. 4, pp. 843-856
2019
-
All-atom catalytic cycle of Lactobacillus nucleoside 2’-deoxyribosyltransferases
BIOTRANS 2019
-
Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer
International Journal of Cancer, Vol. 145, Núm. 7, pp. 1991-2001
-
Reaction mechanism of nucleoside 2′-deoxyribosyltransferases: Free-energy landscape supports an oxocarbenium ion as the reaction intermediate
Organic and Biomolecular Chemistry, Vol. 17, Núm. 34, pp. 7891-7899
2018
-
Characterization of an atypical, thermostable, organic solvent- and acid-tolerant 2′-deoxyribosyltransferase from Chroococcidiopsis thermalis
Applied Microbiology and Biotechnology, Vol. 102, Núm. 16, pp. 6947-6957
-
Enzymatic Synthesis of Therapeutic Nucleosides using a Highly Versatile Purine Nucleoside 2’-DeoxyribosylTransferase from Trypanosoma brucei
ChemCatChem, Vol. 10, Núm. 19, pp. 4406-4416
2014
-
Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): An open-label, randomised phase 3 trial
The Lancet Oncology, Vol. 15, Núm. 11, pp. 1269-1278